Adapthealth Corp Stock Price, News & Analysis

AeroCare Holdings has been acquired by AdaptHealth Corp. in a deal valued at approximately $1.1 billion in cash and 31 million shares of stock. This acquisition allows AeroCare’s shareholders, including management and private investors, to become shareholders of AdaptHealth. AeroCare provides home medical equipment and services to over 1 million patients annually, showcasing 20 years of consecutive revenue growth. The merger is anticipated to enhance operational efficiencies and market leadership in the healthcare sector, addressing the needs of chronically ill patients.

AdaptHealth Corp. (NASDAQ: AHCO) has completed its acquisition of AeroCare Holdings Inc. for approximately $1.1 billion in cash and stock, enhancing its home healthcare services. The deal includes 31 million shares of AdaptHealth common stock, subject to shareholder approval. This acquisition enables AdaptHealth to reach nearly 3 million patients across 46 states through over 500 locations. The company will be co-led by AdaptHealth CEO Luke McGee and AeroCare CEO Steve Griggs while expanding its Board of Directors. The transaction was funded through senior notes and credit facility adjustments.

AdaptHealth Corp. (NASDAQ: AHCO) is set to present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 10:00 am EST. The conference runs from January 11-14, 2021, and will be conducted virtually. Interested parties can access a live webcast and replay via the Investors section on www.adapthealth.com. AdaptHealth is a prominent provider of home medical equipment and services, catering to over 1.8 million patients annually across the U.S. through its network of 269 locations.

AdaptHealth Corp. (NASDAQ: AHCO) has priced its public offering of 8,000,000 shares of Class A Common Stock at $33.00 per share, aiming for gross proceeds of approximately $239.25 million. The offering includes 7,250,000 shares from the Company and 750,000 from a selling stockholder, with a 30-day option for underwriters to purchase an additional 1,200,000 shares. Proceeds will fund the acquisition of AeroCare Holdings, Inc. and general corporate purposes. The offering is set to close on January 8, 2021, pending customary conditions.

AdaptHealth Corp. (NASDAQ: AHCO) has initiated a public offering of 7,000,000 shares of its Class A Common Stock, with an additional 1,000,000 shares offered by certain selling stockholders. The offering may also include a 30-day option for underwriters to purchase up to 1,200,000 additional shares. Proceeds will primarily finance the acquisition of AeroCare Holdings, with the remainder allocated for general corporate purposes. The company will not gain any proceeds from shares sold by selling stockholders, and the offering's completion is independent of the AeroCare acquisition.

AdaptHealth Corp. (NASDAQ: AHCO) has priced a $500 million offering of 4.625% senior notes due 2029. Proceeds will fund the acquisition of AeroCare Holdings, with completion expected in Q1 2021, pending customary conditions. If the acquisition isn’t finalized by May 31, 2021, the notes will be redeemed at 100% of their principal. The offering is exclusively for qualified institutional buyers and has not been registered under the Securities Act. AdaptHealth serves approximately 1.8 million patients across 41 states, providing essential home healthcare equipment and services.

AdaptHealth Corp. (NASDAQ: AHCO) has initiated an offering of $500 million senior notes due 2029 through its subsidiary, AdaptHealth LLC. The proceeds will be held in escrow until the completion of the acquisition of AeroCare Holdings, Inc. The acquisition is projected to close in Q1 2021, with potential redemption of the notes if not completed by May 31, 2021. The notes will be guaranteed by various subsidiaries, and are offered exclusively to qualified institutional buyers. This press release does not constitute an offer to sell securities.

AdaptHealth Corp. (NASDAQ: AHCO) has announced its decision to acquire AeroCare Holdings, Inc. for approximately $2.0 billion. The deal includes $1.1 billion in cash and 31 million shares of AdaptHealth common stock. This merger is expected to enhance AdaptHealth's geographic presence, reaching 47 out of 48 continental US states and solidifying partnerships with healthcare providers. The company also raised its 2021 financial guidance significantly, projecting net revenues of $2.05 billion to $2.20 billion and Adjusted EBITDA of $480 million to $515 million.

AdaptHealth Corp. (NASDAQ: AHCO) reported strong financial results for Q3 2020, with net revenue of $284.4 million, up 108% year-over-year. The company expanded through acquisitions, enhancing its diabetes management and home medical equipment operations. Despite a net loss of $2.5 million, adjusted EBITDA grew significantly to $53.2 million compared to $31.7 million in Q3 2019. The company increased its 2020 revenue guidance to $1.00-$1.04 billion and provided a strong outlook for 2021, projecting $1.30-$1.40 billion in revenue. CEO Luke McGee highlighted the team's dedication amidst challenges.